STBI TEAM

Founders

Don Gann, M.D.

Co-Founder

In Memoriam

1932 - 2020

STBI was founded by Dr. Gann & Dr. Darlington to get their discovery to patients where it can help trauma teams save lives!

Dan Darlington, Ph.D.

Co-Founder & CSO

Leadership Team

Susan, Lewis, and Les have been accelerating the project and now lead the company.

Under the leadership of our team, our company will rely on top Contract Research Organizations (CROs) and Contract Manufacturing Services (CMOs) to ensure efficient execution of our drug development activities.

Execution Support Team

Our Execution Support Team is made up of experts in a range of areas who have and will help us advance this to patients in need.

Derek Cole

Industry / Investor Relations Advisor

President, Investor Relations Advisory Solutions

Chris Regan

Business / Corporate Advisor

Principal, Tower Hill Atlantic

Get in touch:

info@shockbiotech.com

1100 Wicomico Street

Baltimore, MD 21230

  • LinkedIn Social Icon
  • Twitter Social Icon
  • Facebook Social Icon

© 2020 Shock Therapeutics Biotechnologies, Inc.

Proudly Founded & Headquartered in Baltimore, Maryland